In individuals with hepatic injury, barbiturates should be administered with caution and at first in lessened doses. Barbiturates should not be administered to patients displaying the premonitory signs of hepatic coma.pentobarbital will lower the extent or outcome of dasatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/